Sort
82,697 grants matching “vaccine development”
Analysis of breakthrough influenza infections to identify viral and immunological markers of vaccine failure
$689,374National Institute Of Allergy And Infectious Diseases · Y01 · FY2023 · AI
Vervet Research Colony as a Biomedical Resource
$689,364Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2019 · OD
Pharmacy Referral Intervention: IDU Access to Services
$689,300Crystal M Fuller · New York Academy Of Medicine · R01 · FY2008 · DA
Vervet Research Colony as a Biomedical Resource
$689,273Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2018 · OD
HUMAN IMMUNE RESPONSES TO HPV VACCINES
$689,259Johns Hopkins University · P01 · FY2000 · AI
EIAV Envelope Variation and Vaccine Efficacy
$689,250Ronald C Montelaro · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · AI
Development of a Novel, Sensitive ZIKV-Specific Sero-diagnostic Assay Utilizing Biologically Inspired Synthetic Molecules
$689,242Donald S. Burke · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI
Quantifying Immune VS. Viral Killing of SIV Infected and Latently Infected Cells
$689,204Ruy M Ribeiro · Los Alamos Nat Secty-Los Alamos Nat Lab · R01 · FY2014 · AI
Administrative and Coordinating Core
$689,186Margaret M Madeleine · Fred Hutchinson Cancer Center · U54 · FY2025 · CA
Eliminating the latent reservoir by targeted in vivo delivery of HIV-specific CARs
$689,181James L Riley · University Of Pennsylvania · R01 · FY2023 · AI
Optimizing Immunity and Maternal Host Defense Against Congenital Cytomegalovirus Infection
$689,044Mark R. Schleiss · University Of Minnesota · R01 · FY2019 · HD
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses
$689,042Harvinder Singh Gill · Texas Tech University · R01 · FY2021 · AI
Novel Combination Adjuvant for Eliciting Systemic and Mucosal CD8 T Cell Memory
$689,029Marulasiddappa Suresh · University Of Wisconsin-Madison · U01 · FY2020 · AI
Preclinical-Clinical Paramyxovirus Vaccine Development
$688,973Allen Portner · St. Jude Children'S Research Hospital · P01 · FY2007 · AI
Host Immune Responses to Antigens of Malaria Parasites
$688,954Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Defining the role of cytomegalovirus in glioblastoma therapies
$688,910Sean Edward Lawler · Brown University · R01 · FY2022 · CA
Synergistic effects of HIV and age on naive CD4+ T-cell senescence
$688,896Beth D. Jamieson-Karavodin · University Of California Los Angeles · R01 · FY2008 · AG
Clinical trials employing cancer vaccine combination therapies
$688,838James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$688,838James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Immunologic Correlates of Immunization for Cancer
$688,813University Of Washington · U54 · FY2001 · CA
Project 1 Viral Genomics: surveillance, epidemiology, host response, and viral immunogenicity
$688,701Pardis Christine Sabeti · Broad Institute, Inc. · U19 · FY2019 · AI
Host and Parasite Determinants in Human Leishmaniasis
$688,682Edgar M Carvalho · Federal University Of Bahia · P50 · FY2009 · AI
The Burden of Chikungunya and Dengue Transmission, Infection and Disease in Kenya
$688,670Angelle Desiree Labeaud · Children'S Hospital & Res Ctr At Oakland · R01 · FY2013 · AI
MODIFIED ENVELOPE GLYCOPROTEINS FOR HIV1 VACCINE
$688,474Weill Medical College Of Cornell Univ · R01 · FY2000 · AI
Pharmacy Referral Intervention: IDU Access to Services
$688,457Crystal M Fuller · New York Academy Of Medicine · R01 · FY2007 · DA